BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2410195)

  • 1. Regulation of anterior chamber fibrinolysis.
    O'Rourke J; Moore M; Kreutzer DL
    Curr Eye Res; 1985 May; 4(5):569-78. PubMed ID: 2410195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extravascular plasminogen activator and inhibitor activities detected at the site of a chronic mycobacterial-induced inflammation.
    O'Rourke J; Wang WP; Donnelly L; Wang E; Kreutzer DL
    Am J Pathol; 1987 Feb; 126(2):334-42. PubMed ID: 3493701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of impaired anterior segment fibrinolytic activity in chronic uveitis.
    O'Rourke J; Lindsay M; Kreutzer D; Picciano P; Rowland F; Joyner R; Dobrzanski L
    Ophthalmic Res; 1982; 14(4):256-64. PubMed ID: 6752798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elements of the fibrinolytic system.
    Lijnen HR
    Ann N Y Acad Sci; 2001; 936():226-36. PubMed ID: 11460480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A; Shizume K; Cho M; Takada Y
    Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rabbit as a model for studies of fibrinolysis.
    Hassett MA; Krishnamurti C; Barr CF; Alving BM
    Thromb Res; 1986 Aug; 43(3):313-23. PubMed ID: 3488605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity of normal human blood monocytes.
    Grau E; Moroz LA
    Thromb Res; 1989 Jan; 53(2):145-62. PubMed ID: 2922705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in enhancement of plasma fibrinolytic activity by chloroform.
    Moroz LA; Gilmore NJ
    Blood; 1976 Nov; 48(5):777-90. PubMed ID: 135588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
    Guinn L; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):315-20. PubMed ID: 14743974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.